Stock PMVP PMV PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus PMV Pharmaceuticals, Inc.

Equities

PMVP

US69353Y1038

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
1.82 USD +1.68% Intraday chart for PMV Pharmaceuticals, Inc. -10.78% -41.29%
May. 29 PMV Pharmaceuticals, Foundation Medicine to Develop Companion Diagnostic for Rezatapopt MT
May. 29 Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt CI

Evolution of the average Target Price on PMV Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

dcb.4kCFZqL2Hp_iPFKXJQh5t_5t_4jkrC4V7Dz1e1Y31KE.tzrNIeOpU-2PbGvkHFdIzowlmuGt72NFukyTPS59nZSvK8EKw78o-ZZ_PQ~c7577aacdd2d71a9047bac4887d6c5f5

Analyst Recommendations on PMV Pharmaceuticals, Inc.

Jefferies Starts PMV Pharmaceuticals With Buy Rating, $5 Price Target MT
Ladenburg Thalmann Initiates PMV Pharmaceuticals at Buy With $7 Price Target MT
HC Wainwright Cuts Price Target on PMV Pharmaceuticals to $5 From $29, Maintains Buy Rating MT
HC Wainwright Adjusts PMV Pharmaceuticals Price Target to $29 From $35, Maintains Buy Rating MT
HC Wainwright Adjusts Price Target on PMV Pharmaceuticals to $35 From $36, Keeps Buy Rating MT
Oppenheimer Adjusts PMV Pharmaceuticals' Price Target to $15 From $28, Maintains Outperform Rating MT
HC Wainwright Adjusts PMV Pharmaceuticals' Price Target to $36 From $63, Keeps Buy Rating MT
Oppenheimer Adjusts PMV Pharmaceuticals Price Target to $28 From $33, Maintains Outperform Rating MT
Oppenheimer Adjusts PMV Pharmaceuticals Price Target to $33 From $30, Maintains Outperform Rating MT
Goldman Reduces PMV Pharmaceuticals' Price Target to $25 From $43, Buy Rating Kept MT
Oppenheimer Upgrades PMV Pharmaceuticals to Outperform From Perform, Sets $30 Price Target MT
PMV PHARMACEUTICALS : Goldman Sachs Upgrades PMV Pharmaceuticals to Buy From Neutral, Lifts Price Target to $43 From $35 MT
PMV PHARMACEUTICALS : Oppenheimer Initiates Coverage on PMV Pharmaceuticals With Perform Rating MT
PMV PHARMACEUTICALS : Guggenheim Starts PMV Pharmaceuticals at Buy With $56 Price Target MT
PMV PHARMACEUTICALS : HC Wainwright Starts PMV Pharmaceuticals at Buy With $63 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1.82 USD
Average target price
5.75 USD
Spread / Average Target
+215.93%
High Price Target
7 USD
Spread / Highest target
+284.62%
Low Price Target
5 USD
Spread / Lowest Target
+174.73%

Consensus detail

Consensus revision (last 18 months)

Analysts covering PMV Pharmaceuticals, Inc.

Jefferies & Co.
Ladenburg Thalmann
HC Wainwright
Oppenheimer
Goldman Sachs
Guggenheim

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. PMVP Stock
  4. Consensus PMV Pharmaceuticals, Inc.